The Scientist

» clinical trials and culture

Most Recent

In Chapter 12, "The Opium Fields," author Marc Lewis recounts one night spent in the brain chemistry-bending grip of opium addiction.

3 Comments

image: Capsule Reviews

Capsule Reviews

By | May 1, 2012

Masters of the Planet, Learning from the Octopus, Darwin’s Devices, and Psychology’s Ghosts

2 Comments

Contributors

May 1, 2012

Meet some of the people featured in the April 2012 issue of The Scientist.

0 Comments

image: Dopamine: Duality of Desire

Dopamine: Duality of Desire

By | May 1, 2012

Being an ex-drug-addict turned neuroscientist brings a unique insight into the physiological and phenomenological realities of addiction.

0 Comments

image: With All Due Consideration

With All Due Consideration

By | May 1, 2012

Scientists and their many hats

2 Comments

image: Data Diving

Data Diving

By | May 1, 2012

What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.

28 Comments

image: Speaking of Science

Speaking of Science

By | May 1, 2012

May 2012's selection of notable quotes

8 Comments

image: Opinion: Data to Knowledge to Action

Opinion: Data to Knowledge to Action

By | April 18, 2012

Introducing DELSA Global, a community initiative to connect experts, share data, and democratize science.

2 Comments

image: Scottish DNA Unexpectedly Diverse

Scottish DNA Unexpectedly Diverse

By | April 18, 2012

Geography might explain the treasure trove of genetic diversity among Scots.

2 Comments

image: Repurpose Failed Drugs, NIH Urges

Repurpose Failed Drugs, NIH Urges

By | April 16, 2012

Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.

0 Comments

Advertisement
RayBiotech
RayBiotech

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Shimadzu Scientific
Shimadzu Scientific
Advertisement
The Scientist